Alzheimer's disease (AD) and COVID-19 share many common risk factors, such as
advanced age, complications, APOE genotype, etc. Epidemiological studies have also …

BackgroundPeople with neurodegenerative disease and mild cognitive impairment (MCI)
may have an elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 …

Introduction: In early 2020, the novel SARS-CoV-2 virus began to spread around the world
and claim victims. Initially, in the Western world, COVID-19-related mortality was due to …

OBJECTIVE: COVID-19 infection can cause impairments in many cognitive areas. The aim
of the present study was to evaluate the cognitive functions of patients who had been …

Introduction We report the COVID‐19 pandemic's impact on health‐care use disruption
among people with mild cognitive impairment or Alzheimer's disease and related dementia …

Evidence suggests that SARS-CoV-2 entry into the central nervous system can result in
neurological and/or neurodegenerative diseases. In this review, routes of SARS-Cov-2 entry …

Background: The identification of risk factors for SARS-CoV-2 infection and mortality in
patients with dementia is a key aspect to support clinical decisions and public health …

This research explored experiences across three cognitive function groups (no impairment,
mild impairment, and dementia) with respect to shielding (either self-isolating or staying at …

The purpose of this study was to identify hub genes closely correlated with Alzheimer′ s
disease (AD) and their association with immune cell infiltration. In this work, 119 overlapping …

Acknowledging the neurological symptoms of COVID‐19 and the long‐lasting neurological
damage even after the epidemic ends are common, necessitating ongoing vigilance. Initial …